Skip to main content

Bone Formation Versus Bone Resorption in Ankylosing Spondylitis

  • Chapter
Molecular Mechanisms of Spondyloarthropathies

Part of the book series: Advances in Experimental Medicine and Biology ((volume 649))

Abstract

Ankylosing spondylitis (AS) and other forms of seronegative spondylarthritis (SpA) are characterized by two major processes in joints—the first is chronic inflammation and the second is progressive ankylosis. Both features go hand-in-hand and determine the clinical picture of disease, which is joint pain, progressive stiffness and, in case of peripheral joint involvement also joint swelling. The interplay between inflammation and ankylosis is best illustrated in AS, where chronic inflammation of the spine leads to progressive stiffness, reduced spinal mobility and kyphosis. AS may thus be considered as a synthesis of inflammatory disease and bone disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Braun J, Landewé R, Hermann KG et al. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 2006; 54:1646–52.

    Article  PubMed  CAS  Google Scholar 

  2. Davis J, van der Heijde D, Braun J et al. Recombinant human tumor necrosis factor receptor (Etanercept) for treating ankylosing spondylitis A randomized, controlled trial. Arthritis Rheum 2003; 48:3230–6

    Article  PubMed  CAS  Google Scholar 

  3. van der Heijde D, Kivitz A, Schiff M et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006:54:2136–2.

    Article  PubMed  Google Scholar 

  4. Schett G, Landewé R, Desiree van der Heijde D. TNF blockers and structural remodeling in ankylosing spondylitis-what is reality and what is fiction? Ann Rheum Dis 2007; 66:709–11.

    Article  PubMed  CAS  Google Scholar 

  5. Schett G, Redlich K, Smolen JS. Inflammation-induced bone loss in the rheumatic diseases. In: Favus MJ, Ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th Edition. Washington D.C.: ASBMR, 2006; 6:310–313.

    Google Scholar 

  6. Gravallese EM, Harada Y, Wang JT et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998; 152:943–951.

    PubMed  CAS  Google Scholar 

  7. Boers M, Kostense PJ, Verhoeven AC et al. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis. Arthritis Rheum 2001; 44:2242–6.

    Article  PubMed  CAS  Google Scholar 

  8. Scott DL, Pugner K, Kaarela K et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000; 39:122–132.

    Article  CAS  Google Scholar 

  9. Storm EE, Kingsley DM. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 1996; 122:3969–79.

    PubMed  CAS  Google Scholar 

  10. Hartmann C, Tabin CJ. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 2001; 104:341–51.

    Article  PubMed  CAS  Google Scholar 

  11. Benjamin M, McGonagle D. The anatomical basis for disease localization in seronegative spondylar-thropathy at entheses and related sites. J Anat 2001; 199:503–526.

    Article  PubMed  CAS  Google Scholar 

  12. Ball J. Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis 1971; 30(3):213–23.

    Article  PubMed  CAS  Google Scholar 

  13. Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005; 115:1571–9.

    Article  PubMed  CAS  Google Scholar 

  14. Appel H, Kuhne M, Spiekermann S et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006; 54(9):2845–51.

    Article  PubMed  Google Scholar 

  15. Scharstuhl A, Vitters EL, van der Kraan PM et al. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 2003; 48:3442–51.

    Article  PubMed  CAS  Google Scholar 

  16. Lories RJ, Derese I, de Bari C et al. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 2007; 56(2):489–97.

    Article  PubMed  Google Scholar 

  17. Lories RJ, Matthys P, de Vlam K et al. Ankylosing enthesitis, dactylitis and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis 2004; 63(5):595–8.

    Article  PubMed  CAS  Google Scholar 

  18. Miller JR. The Wnts. Genome Biol 2002; 3(1):3001.

    Google Scholar 

  19. Diarra D, Stolina M, Polzer K et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13:156–163.

    Article  PubMed  CAS  Google Scholar 

  20. Lories R, Peeters J, Bakker A et al. Deletion of Frzb affects articular cartilage and biomechanical poperties of the long bones. Arthritis Rheum 2007, in press.

    Google Scholar 

  21. McInnes I, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Immunol 2007; 7:429–442.

    Article  CAS  Google Scholar 

  22. Gough AK, Lilley J, Eyre S et al. Generalized bone loss in patients with early rheumatoid arthritis. Lancet 1994; 344:23–27.

    Article  PubMed  CAS  Google Scholar 

  23. Ralston SH, Urquhart GD, Brzeski M et al. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 1990; 300:563–565.

    Article  PubMed  CAS  Google Scholar 

  24. Schett G, Kiechl S, Weger S et al. High-sensitivity C-reaktive protein and risk of nontraumatic fractures in the bruneck study. Arch Int Med 2006; 166:2495–501.

    Article  CAS  Google Scholar 

  25. Appel H, Loddenkemper C, Grozdanovic Z et al. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006; 22:R143.

    Article  Google Scholar 

  26. Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007; 56:1118–24.

    Article  PubMed  Google Scholar 

  27. Gortz B, Hayer S, Redlich K et al. Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. J Bone Miner Res 2004; 19(6):990–8.

    Article  PubMed  CAS  Google Scholar 

  28. Glass DA, Bialek P, Ahn JD et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005; 8:751–64.

    Article  PubMed  CAS  Google Scholar 

  29. van der Heijde DM, Landewé RB, Ory P et al. Two-year etanercept therapy does not inhibit radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2006; 65(Suppl II):81.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Landes Bioscience and Springer Science+Business Media

About this chapter

Cite this chapter

Schett, G. (2009). Bone Formation Versus Bone Resorption in Ankylosing Spondylitis. In: López-Larrea, C., Díaz-Peña, R. (eds) Molecular Mechanisms of Spondyloarthropathies. Advances in Experimental Medicine and Biology, vol 649. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0298-6_8

Download citation

Publish with us

Policies and ethics